2024/10/18 21:31:00 | |
---|---|
Price | |
0.0076 USD | |
Difference | 3,675.00% (0.01) |
ISIN | US24984K1051 |
Symbol | DMTK |
Exchange | FINRA other OTC Issues |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.0001 USD |
High | 0.0076 USD |
Low | 0.0001 USD |
Close (prev. day) | 0.0002 USD |
VWAP | 0.000177 USD |
Volume (pcs) | 16,886 |
Trading volume | 3.01 |
Number of trades | 26 |
Last size | 100 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/10/08 | Global Strategy 4Q 2024 | ||
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings |
2024/10/18 21:31:00 | |
---|---|
Price | |
0.0076 USD | |
Difference | 3,675.00% (0.01) |
ISIN | US24984K1051 |
Symbol | DMTK |
Exchange | FINRA other OTC Issues |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 0 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.0001 USD |
High | 0.0076 USD |
Low | 0.0001 USD |
Close (prev. day) | 0.0002 USD |
VWAP | 0.000177 USD |
Volume (pcs) | 16,886 |
Trading volume | 3.01 |
Number of trades | 26 |
Last size | 100 |
6m | 1Y | 3Y | |
Perf (%) | -98.72% | -99.41% | -99.98% |
Perf (abs.) | -0.58 | -1.27 | -31.13 |
Beta | -9.04 | -10.19 | -5.11 |
Volatility | 939.00 | 667.85 | 396.65 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.0106 USD (147,679) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.0212 USD (97,431) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.0838 USD (1,016,076) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.6901 USD (692,365) |
YTD High | date | 1.7799 USD (2024/01/02) |
YTD Low | date | 0.0001 USD (2024/10/16) |
52 Weeks High | date | 1.9900 USD (2023/12/27) |
52 Weeks Low | date | 0.0001 USD (2024/10/16) |
- |
Matthew Posard | Chairman of Board of Directors |
Kirk Malloy | Member of Board of Directors |
Cynthia Collins | Member of Board of Directors |
Herman Rosenman | Member of Board of Directors |
Mark Capone | Member of Board of Directors |
Nathalie Keraudy | Member of Board of Directors |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer